These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1002 related items for PubMed ID: 18981372

  • 1. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, EHDI Study Group, Roos RA.
    Neurology; 2008 Nov 04; 71(19):1506-13. PubMed ID: 18981372
    [Abstract] [Full Text] [Related]

  • 2. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P.
    J Neurochem; 2001 Aug 04; 78(4):694-703. PubMed ID: 11520890
    [Abstract] [Full Text] [Related]

  • 3. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ, Glynn D, Leavens W, Zheng Z, Faull RL, Skepper JN, Wight JM.
    Neurobiol Dis; 2009 Mar 04; 33(3):331-41. PubMed ID: 19130884
    [Abstract] [Full Text] [Related]

  • 4. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH, Charles V, Williams M, Miller G, Whetsell WO, Tagle DA.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1035-45. PubMed ID: 10434303
    [Abstract] [Full Text] [Related]

  • 5. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, André VM, Cepeda C, Watson JB, Levine MS.
    J Neurophysiol; 2012 Jan 29; 107(2):677-91. PubMed ID: 22072510
    [Abstract] [Full Text] [Related]

  • 6. Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease.
    Schiefer J, Landwehrmeyer GB, Lüesse HG, Sprünken A, Puls C, Milkereit A, Milkereit E, Kosinski CM.
    Mov Disord; 2002 Jul 29; 17(4):748-57. PubMed ID: 12210870
    [Abstract] [Full Text] [Related]

  • 7. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A, Dragileva E, Teed A, Espinola J, Fossale E, Gillis T, Lopez E, Myers RH, MacDonald ME, Wheeler VC.
    Hum Mol Genet; 2006 Jun 15; 15(12):2015-24. PubMed ID: 16687439
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease.
    Aziz NA, Pijl H, Frölich M, Schröder-van der Elst JP, van der Bent C, Roelfsema F, Roos RA.
    Eur J Neurol; 2010 Feb 15; 17(2):280-8. PubMed ID: 19845749
    [Abstract] [Full Text] [Related]

  • 9. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JS, Mori S, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Pomper MG, Osmand AP, Guilarte TR, Bowman AB.
    J Huntingtons Dis; 2015 Feb 15; 4(1):17-36. PubMed ID: 26333255
    [Abstract] [Full Text] [Related]

  • 10. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
    Panegyres PK, Goh JG.
    J Neurol Sci; 2011 Feb 15; 301(1-2):14-20. PubMed ID: 21147489
    [Abstract] [Full Text] [Related]

  • 11. Increased metabolism in the R6/2 mouse model of Huntington's disease.
    van der Burg JM, Bacos K, Wood NI, Lindqvist A, Wierup N, Woodman B, Wamsteeker JI, Smith R, Deierborg T, Kuhar MJ, Bates GP, Mulder H, Erlanson-Albertsson C, Morton AJ, Brundin P, Petersén A, Björkqvist M.
    Neurobiol Dis; 2008 Jan 15; 29(1):41-51. PubMed ID: 17920283
    [Abstract] [Full Text] [Related]

  • 12. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ, Wood NI, Morton AJ.
    J Huntingtons Dis; 2016 Oct 01; 5(3):271-283. PubMed ID: 27662335
    [Abstract] [Full Text] [Related]

  • 13. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
    Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Petersén A, Hayden MR.
    Brain; 2009 Apr 01; 132(Pt 4):919-32. PubMed ID: 19224899
    [Abstract] [Full Text] [Related]

  • 14. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C, Cooper JM, Schapira AH.
    Mov Disord; 2007 Sep 15; 22(12):1715-21. PubMed ID: 17557337
    [Abstract] [Full Text] [Related]

  • 15. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV.
    Behav Brain Res; 2007 Mar 12; 178(1):90-7. PubMed ID: 17239451
    [Abstract] [Full Text] [Related]

  • 16. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J, Chen K, Wei Q, Chen Y, Cao B, Burgunder JM, Shang HF.
    Neurol Res; 2016 Oct 12; 38(10):916-20. PubMed ID: 27483361
    [Abstract] [Full Text] [Related]

  • 17. Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.
    Kielar C, Morton AJ.
    J Huntingtons Dis; 2018 Oct 12; 7(1):61-76. PubMed ID: 29480204
    [Abstract] [Full Text] [Related]

  • 18. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA, van Belzen MJ, Coops ID, Belfroid RD, Roos RA.
    Eur J Med Genet; 2011 Oct 12; 54(4):e413-8. PubMed ID: 21540131
    [Abstract] [Full Text] [Related]

  • 19. Systemic energy homeostasis in Huntington's disease patients.
    Aziz NA, Pijl H, Frölich M, Snel M, Streefland TC, Roelfsema F, Roos RA.
    J Neurol Neurosurg Psychiatry; 2010 Nov 12; 81(11):1233-7. PubMed ID: 20710011
    [Abstract] [Full Text] [Related]

  • 20. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
    Ishiguro H, Yamada K, Sawada H, Nishii K, Ichino N, Sawada M, Kurosawa Y, Matsushita N, Kobayashi K, Goto J, Hashida H, Masuda N, Kanazawa I, Nagatsu T.
    J Neurosci Res; 2001 Aug 15; 65(4):289-97. PubMed ID: 11494364
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.